Melanoma arising from blue naevus is an exceedingly rare variant of melanoma. Most of the cases are located in head and neck area, with scalp the most affected site. This type of melanoma develops on blue naevus or resembles blue naevus, most frequently cellular blue naevus. We present the case of a 52 years old female diagnosed with a pigmented melanoma of the scalp, with maximum tumoral thickness of 6.8 mm and invasion of the hypodermis, highly resembling cellular blue naevus.
were ∼ 10% and focally 25%. Some tumor nuclei were positive for Cyclin D1 and p21 (∼ 10%). The nuclear positivity for p53 was faint. β Catenin presented only membrane staining, without nuclear positivity. The tumor cells were negative for AE1-AE3, p16, EMA, CK 8/18 and MMP1. The final diagnosis was melanoma arising from blue naevus, Breslow index 6.8 mm, Clark level V, mitotic index = 11 mitoses/mm 2 , perivascular and perineural invasion -present, no vascular emboli, no ulceration, no tumor infiltrating lymphocytes and no microscopic satellites. The tumor was entirely resected, with a distance to the closer lateral surgical margin of 2.6 mm and a distance to the closer profound surgical margin of 0.15 mm. TNM pathological classification was pT4a Nx. Further imagistic investigations were performed and no lymph node or distant metastases were identified. Re-resection with oncological limits have to be evaluated and performed given the fact that the scalp localization of the tumor is relatively difficult to manage.
DISCUSSION
Melanoma arising from blue naevus is an extremely rare variant of melanoma, in a large USA study represented approximately 0.02% of melanoma cases [4] . The scalp localization is frequent for this variant of melanoma [1] [2] [3] [4] . Clinically and dermatoscopically this type of rare melanoma can resemble nodular melanoma, metastatic melanoma or blue naevus. A benign, blue naevus component can be identified, represented by cellular blue naevus most frequently followed by common blue naevus, naevus of Ota, naevus of Ito and ocular melanocytosis [1] . Clinical examination, dermoscopic examination and reflectance confocal microscopy of blue naevi are difficult because of the variability of aspects, because the symptoms of malignant transformation are poor and arise late in the disease [5] [6] [7] [8] [9] ; moreover, the thickness of the lesion impairs dermoscopic or reflectance confocal microscopic examination. Blue naevi with satellite lesions represent an important clinical challenge in differentiation diagnosis of melanoma [5, 6, 10] . A wide spectrum of dermatoscopic aspects (whitish, scar-like depigmentation, dots, globules, peripheral streaks or vessels) may be observed in blue naevi [9] . In such difficult cases, clinical and dermatoscopic exclusion of diagnosis of malignant melanoma may be impossible, and surgical excision is necessary.
Final diagnosis is established based on histopathological examination of the lesion, incisional or more indicated excisional biopsy being performed.
Microscopic examination revealed in many cases a benign blue naevus component, easily identified, [11] [12] [13] with a component of malignant transformation. It must be differentiated from malignant melanoma associated with blue naevus [14] . In such cases the malignant melanoma juxtaposed to a benign blue naevus component, usually a cellular blue naevus. It represents an association of two lesions or a collision tumor, not a true malignant transformation of blue naevus. The melanoma component (frequently a superficial spreading melanoma) has an epidermal involvement in this situation, in contrast to the typical absence of this aspect in definition of melanoma arising from blue naevus (or "malignant blue naevus").
In other cases [15--17] , such our case, there is a complete transformation of cellular blue naevus. The diagnosis is made by architecture and cytology resemblance with a blue naevus, but with typical presence of aspects of malignancy: nuclear pleomorphism, prominent nucleoli, some infiltrative pattern, tumoral necrosis, high mitotic rate with atypical mitosis and high Ki67 index. Perivascular lymphocytic infiltration and infiltrative growth pattern are also clues in diagnosis of malignancy in blue melanocytic lesions. In our case architecture and cytology resemble cellular blue naevus in the center of the lesion and common blue naevus at the perifery.
The most important differential diagnosis is the more common melanocytic lesion of cellular blue naevus. Because necrosis is quite specific for malignancy, but rare in this variant of melanoma, the most important criteria of malignancy are represented by nuclear pleomorphism, prominent nucleoli, high mitotic rate with presence of atypical mitosis and high Ki67 index. Intermediate cases (without all the criteria necessary for diagnosis of melanoma) between melanomas arising from blue naevus and cellular benign blue naevi are represented by a gray category of tumors called atypical cellular blue nevi or cellular blue nevi with atypical features [18, 19] . An important study [18] indicates that there is substantial confusion and disagreement among experienced histopathologists about the definitions and biologic nature of cellular blue melanocytic neoplasms particularly those thought to have atypical features ("atypical" cellular blue naevi). In some of these borderline cases, a definitive diagnosis of malignant melanoma can be made only after a follow-up for several years [18] .
A cutaneous metastasis with prominent epidermal sparing can mimic a melanoma arising from blue naevus [20] . A careful and complete examination of the skin for a possible primary malignant melanoma must be performed to exclude a metastasis.
Other melanocytic lesions in the differential diagnosis, much more rare than cellular blue naevi or metastatic melanoma, include neurocristic cutaneous hamartoma [21, 22] , neurocutaneous melanosis [21] , paraganglioma-like dermal melanocytic tumor [23] , animal type melanoma or pigmented epithelioid melanocytoma [1, 24] . Melanin pigmentation in our case was focally present compared to heavy pigmentation in animal type melanoma.
Immunohistochemical analyses revealed a typical expression for S100 protein, HMB45, Melan A, Tyrosinase (T311) and Mitf and a typical negativity for p53, β Catenin, AE1-AE3, EMA and CK 8/18. The loss of expression of p16 seems to be suggestive for melanoma in blue melanocytic lesions [25] . The high ki 67 index (∼ 10% and focally 25% in our case) is the most important immunohistochemical marker [1] in diagnosis of malignant melanocytic blue lesions. The expression of p21 and cyclin D1 was low and insignificant.
Immunohistochemical evaluation of changes in the extracellular matrix represented by tissue inhibitor of metalloproteinase (TIMP), matrix metalloproteinase (MMP) and e-cadherin is not specific, with a loss of expression of MMP1 compared with preserved expression of E-Cadherin, MMP2, MMP3, MMP9, MMP11, MMP13, TIMP1, TIMP2 and TIMP3.
Presence of the positivity (membranar) for c-kit in this case can be used, as in other types of malignant melanoma, in prognosis (favorable prognostic with improved outcome in recurrence and metastases) and in treatment with imatinib [26, 27, 28] . 100 Molecular analysis with fluorescence in situ hybridization (FISH) targeting commonly altered chromosomal loci in melanoma and comparative genomic hybridization (CGH) can be used in selected cases to distinguish between malignant and benign blue melanocytic tumors [29, 30, 31] .
Further imagistic investigations were performed and no lymph node or distant metastases were identified. So, general prognosis and treatment of this case is similar to a malignant melanoma in stage IIC (pT4b N0 M0) [4, 32] .
Re-resection in the department of plastic surgery with oncological margins has to be evaluated and performed, given the fact that the scalp localization and the size of the tumor are relatively difficult to manage. 
